LY6G6F anticorps (N-Term)
Aperçu rapide pour LY6G6F anticorps (N-Term) (ABIN630316)
Antigène
Voir toutes LY6G6F AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- C6 ORF21 antibody was raised against the N terminal Of C6 rf21
-
Purification
- Purified
-
Immunogène
- C6 ORF21 antibody was raised using the N terminal Of C6 rf21 corresponding to a region with amino acids CSPAAGSFTTLVAQVQVGRPAPDPGKPGRESRLRLLGNYSLWLEGSKEED
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
C6ORF21 Blocking Peptide, (ABIN937199), is also available for use as a blocking control in assays to test for specificity of this C6ORF21 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C0 RF21 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LY6G6F (Lymphocyte Antigen 6 Complex, Locus G6F (LY6G6F))
-
Autre désignation
- C6ORF21
-
Sujet
- C6ORF21 may play a role in the downstream signal transduction pathways involving GRB2 and GRB7.
-
Poids moléculaire
- 31 kDa (MW of target protein)
Antigène
-